This cytokine has been already implicated in promoting tolerance of melanoma cells to BRAF inhibition, and its receptor C-X-C motif chemokine receptor 2 (CXCR2) was suggested as a potential target in melanoma [80]. The gene discussed is BRAF; the disease is melanoma.